Motus GI Holdings, Inc. (MOTS)

NASDAQ: MOTS · IEX Real-Time Price · USD
0.261
-0.005 (-1.92%)
At close: Jun 24, 2022 4:00 PM
0.277
+0.017 (6.329%)
After-hours: Jun 24, 2022 5:45 PM EDT
-1.92%
Market Cap 14.35M
Revenue (ttm) 360,000
Net Income (ttm) -19.20M
Shares Out 55.06M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 471,148
Open 0.265
Previous Close 0.266
Day's Range 0.261 - 0.279
52-Week Range 0.235 - 1.110
Beta 2.39
Analysts Buy
Price Target 1.17 (+348.8%)
Earnings Date Aug 11, 2022

About MOTS

Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida. [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Feb 14, 2018
CEO Timothy Moran
Employees 30
Stock Exchange NASDAQ
Ticker Symbol MOTS
Full Company Profile

Financial Performance

In 2021, MOTS's revenue was $391,000, an increase of 298.98% compared to the previous year's $98,000. Losses were -$19.03 million, -1.16% less than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 1.17, which is an increase of 348.79% from the latest price.

Price Target
$1.17
(348.79% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at...

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation

Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

FORT LAUDERDALE, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cli...

Will Motus GI Holdings, Inc. (MOTS) Report Negative Earnings Next Week? What You Should Know

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

Motus GI Holdings, Inc. (MOTS) Reports Q4 Loss, Misses Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 0% and 27.21%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Motus GI Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

FORT LAUDERDALE, Fla., March 29, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve ...

Motus GI to Release Fourth Quarter and Full Year 2021 Results and Provide a Business Update on March 29

FORT LAUDERDALE, Fla., March 15, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

Motus GI to Participate in Two Upcoming Investor Conferences in March 2022

FORT LAUDERDALE, Fla., March 02, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve c...

Trading Penny Stocks? Top Stock Market News for February 14th, 2022

Check these penny stocks out for your watchlist today The post Trading Penny Stocks? Top Stock Market News for February 14th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...

Other symbols: BDSIKAVL

Motus GI Receives FDA Clearance to Market the Pure-Vu® EVS System

-All New Pure-Vu EVS offers rapid set-up, improved navigation and enhanced cleansing capabilities to support expanded clinical utilization

Motus GI Announces U.S. Patent For The Pure-Vu® System's Automatic Self-Purging Features

Expanding patent portfolio extends first-mover advantage in the colonoscopy procedure market, estimated at close to 55M global procedures per year Expanding patent portfolio extends first-mover advantag...

Motus GI Reports Third Quarter 2021 Financial Results and Provides Corporate Update

FORT LAUDERDALE, Fla., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

Motus GI Hldgs Earnings Preview

Motus GI Hldgs (NASDAQ:MOTS) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.

Motus GI Holdings, Inc. (MOTS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Motus GI Holdings, Inc. (MOTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Motus GI to Release Third Quarter Results and Provide a Business Update on November 12

FORT LAUDERDALE, Fla., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

Motus GI Announces the Passing of Independent Director Dr. Sam Nussbaum

FORT LAUDERDALE, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) ("Motus GI" or the "Company") announced with profound sadness that Samuel R. Nussbaum, MD, an independent...

Motus GI Announces Enrollment of Patients at Second Site in the European Union Outpatient Study of the Pure-Vu® System

FORT LAUDERDALE, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

Motus GI Holdings, Inc. (MOTS) Reports Q2 Loss, Tops Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.09% and 20.48%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Motus GI to Release Second Quarter Results and Provide a Business Update on August 12

FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

Motus GI to Present at the Ladenburg Thalmann Healthcare Conference

FORT LAUDERDALE, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve cl...

Motus GI Appoints Experienced Financial Biotech Executive, Sonja Nelson, to its Board of Directors and as Chair of Au...

FORT LAUDERDALE, Fla., June 23, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve c...

Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology

FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve cl...

Motus GI's Pure-Vu System® Adopted by Sinai Hospital of Baltimore

Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of ...

7 Cheap Stocks to Buy Now Under $3

It can be difficult to find cheap stocks worth buying. But these seven companies look promising and are all under $3.

Other symbols: BHATBIOLCTRMAUMNWTRH

Motus GI Holdings, Inc. (MOTS) Reports Q1 Loss, Tops Revenue Estimates

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -10.00% and 27.50%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?